Citation 131131

SHARMA,S: STUTZMANN,JD: KELLOFF,GJ: STEELE,VE:. (1994). SCREENING OF POTENTIAL CHEMOPREVENTIVE AGENTS USING BIOCHEMICAL MARKERS OF CARCINOGENESIS.. 54(22)

Citation Details

Title	SCREENING OF POTENTIAL CHEMOPREVENTIVE AGENTS USING BIOCHEMICAL MARKERS OF CARCINOGENESIS.
Authors	SHARMA,S: STUTZMANN,JD: KELLOFF,GJ: STEELE,VE:
Year	1994
Volume	54
Issue	22

Summary

Year: 1994

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MEVINOLIN	ACTIVE
2	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MEVINOLIN	ACTIVE
3	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MEVINOLIN	INACTIVE
4	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	MEVINOLIN	ACTIVE
5	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	MEVINOLIN	ACTIVE
6	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MEVINOLIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASCORBIC ACID PALMITATE	ACTIVE
2	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASCORBIC ACID PALMITATE	ACTIVE
3	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASCORBIC ACID PALMITATE	ACTIVE
4	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ASCORBIC ACID PALMITATE	ACTIVE
5	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASCORBIC ACID PALMITATE	ACTIVE
6	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ASCORBIC ACID PALMITATE	INACTIVE
7	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	INACTIVE
8	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	ACTIVE
9	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	ACTIVE
10	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	ACTIVE
11	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	ACTIVE
12	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	ACTIVE
13	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CARBENOXOLONE*	INACTIVE
14	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CARBENOXOLONE*	ACTIVE
15	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CARBENOXOLONE*	INACTIVE
16	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CARBENOXOLONE*	INACTIVE
17	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	CARBENOXOLONE*	ACTIVE
18	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CARBENOXOLONE*	ACTIVE
19	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CARNOSINE,L:	ACTIVE
20	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CARNOSINE,L:	ACTIVE
21	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CARNOSINE,L:	ACTIVE
22	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CARNOSINE,L:	INACTIVE
23	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	CARNOSINE,L:	INACTIVE
24	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CARNOSINE,L:	ACTIVE
25	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAROTENE,BETA: TRANS:	ACTIVE
26	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAROTENE,BETA: TRANS:	ACTIVE
27	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAROTENE,BETA: TRANS:	INACTIVE
28	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CAROTENE,BETA: TRANS:	ACTIVE
29	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAROTENE,BETA: TRANS:	ACTIVE
30	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CAROTENE,BETA: TRANS:	ACTIVE
31	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
32	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
33	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
34	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	INACTIVE
35	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
36	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
37	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID	INACTIVE
38	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID	ACTIVE
39	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID	ACTIVE
40	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID	INACTIVE
41	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID	ACTIVE
42	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID	INACTIVE
43	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROPHYLL	ACTIVE
44	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROPHYLL	INACTIVE
45	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROPHYLL	INACTIVE
46	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROPHYLL	INACTIVE
47	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROPHYLL	INACTIVE
48	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROPHYLL	INACTIVE
49	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	INACTIVE
50	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	INACTIVE
51	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	ACTIVE
52	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	INACTIVE
53	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	ACTIVE
54	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	ACTIVE
55	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DIALLYL DISULFIDE	ACTIVE
56	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DIALLYL DISULFIDE	INACTIVE
57	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DIALLYL DISULFIDE	ACTIVE
58	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	DIALLYL DISULFIDE	ACTIVE
59	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	DIALLYL DISULFIDE	ACTIVE
60	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DIALLYL DISULFIDE	INACTIVE
61	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DIALLYL SULFIDE	ACTIVE
62	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DIALLYL SULFIDE	ACTIVE
63	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DIALLYL SULFIDE	ACTIVE
64	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	DIALLYL SULFIDE	ACTIVE
65	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	DIALLYL SULFIDE	INACTIVE
66	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DIALLYL SULFIDE	INACTIVE
67	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID	ACTIVE
68	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID	INACTIVE
69	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID	ACTIVE
70	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID	INACTIVE
71	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID	ACTIVE
72	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID	ACTIVE
73	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULETIN	ACTIVE
74	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULETIN	ACTIVE
75	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULETIN	ACTIVE
76	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULETIN	ACTIVE
77	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULETIN	ACTIVE
78	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULETIN	ACTIVE
79	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VANILLIN,ETHYL:	ACTIVE
80	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VANILLIN,ETHYL:	INACTIVE
81	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VANILLIN,ETHYL:	INACTIVE
82	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	VANILLIN,ETHYL:	INACTIVE
83	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	VANILLIN,ETHYL:	ACTIVE
84	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	VANILLIN,ETHYL:	ACTIVE
85	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUMARIC ACID	ACTIVE
86	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUMARIC ACID	ACTIVE
87	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUMARIC ACID	INACTIVE
88	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FUMARIC ACID	INACTIVE
89	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUMARIC ACID	ACTIVE
90	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FUMARIC ACID	INACTIVE
91	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCARIC ACID	ACTIVE
92	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCARIC ACID	ACTIVE
93	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCARIC ACID	ACTIVE
94	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCARIC ACID	ACTIVE
95	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCARIC ACID	ACTIVE
96	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCARIC ACID	INACTIVE
97	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYRRHETINIC ACID,18-BETA:	ACTIVE
98	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYRRHETINIC ACID,18-BETA:	ACTIVE
99	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYRRHETINIC ACID,18-BETA:	INACTIVE
100	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYRRHETINIC ACID,18-BETA:	ACTIVE
101	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYRRHETINIC ACID,18-BETA:	ACTIVE
102	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYRRHETINIC ACID,18-BETA:	ACTIVE
103	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	INDOLE-3-CARBINOL	ACTIVE
104	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	INDOLE-3-CARBINOL	ACTIVE
105	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	INDOLE-3-CARBINOL	ACTIVE
106	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	INDOLE-3-CARBINOL	ACTIVE
107	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	INDOLE-3-CARBINOL	ACTIVE
108	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	INDOLE-3-CARBINOL	ACTIVE
109	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIMONENE,(+):	ACTIVE
110	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIMONENE,(+):	ACTIVE
111	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIMONENE,(+):	INACTIVE
112	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	LIMONENE,(+):	ACTIVE
113	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIMONENE,(+):	ACTIVE
114	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LIMONENE,(+):	INACTIVE
115	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NICOTINIC ACID	ACTIVE
116	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NICOTINIC ACID	ACTIVE
117	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NICOTINIC ACID	ACTIVE
118	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	NICOTINIC ACID	ACTIVE
119	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	NICOTINIC ACID	ACTIVE
120	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NICOTINIC ACID	INACTIVE
121	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GUAIARETIC ACID,NOR-DIHYDRO:	ACTIVE
122	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GUAIARETIC ACID,NOR-DIHYDRO:	ACTIVE
123	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GUAIARETIC ACID,NOR-DIHYDRO:	ACTIVE
124	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GUAIARETIC ACID,NOR-DIHYDRO:	ACTIVE
125	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	GUAIARETIC ACID,NOR-DIHYDRO:	INACTIVE
126	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GUAIARETIC ACID,NOR-DIHYDRO:	INACTIVE
127	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THIOCYANATE,ISO: PHENETHYL:	INACTIVE
128	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THIOCYANATE,ISO: PHENETHYL:	ACTIVE
129	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THIOCYANATE,ISO: PHENETHYL:	INACTIVE
130	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	THIOCYANATE,ISO: PHENETHYL:	INACTIVE
131	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	THIOCYANATE,ISO: PHENETHYL:	ACTIVE
132	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	THIOCYANATE,ISO: PHENETHYL:	INACTIVE
133	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROGESTERONE	ACTIVE
134	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROGESTERONE	ACTIVE
135	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROGESTERONE	ACTIVE
136	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	PROGESTERONE	ACTIVE
137	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROGESTERONE	ACTIVE
138	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROGESTERONE	INACTIVE
139	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID PROPYL ESTER	ACTIVE
140	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID PROPYL ESTER	ACTIVE
141	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID PROPYL ESTER	ACTIVE
142	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID PROPYL ESTER	ACTIVE
143	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID PROPYL ESTER	ACTIVE
144	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID PROPYL ESTER	INACTIVE
145	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PURPURIN	ACTIVE
146	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PURPURIN	ACTIVE
147	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PURPURIN	INACTIVE
148	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	PURPURIN	ACTIVE
149	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	PURPURIN	ACTIVE
150	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PURPURIN	INACTIVE
151	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
152	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
153	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	INACTIVE
154	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	INACTIVE
155	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
156	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	INACTIVE
157	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RETINOIC ACID,ALL-TRANS:	ACTIVE
158	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RETINOIC ACID,ALL-TRANS:	ACTIVE
159	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RETINOIC ACID,ALL-TRANS:	INACTIVE
160	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	RETINOIC ACID,ALL-TRANS:	ACTIVE
161	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	RETINOIC ACID,ALL-TRANS:	ACTIVE
162	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RETINOIC ACID,ALL-TRANS:	ACTIVE
163	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	ACTIVE
164	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	ACTIVE
165	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	INACTIVE
166	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	INACTIVE
167	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	ACTIVE
168	KETOSIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	INACTIVE
169	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SELENOMETHIONINE,(DL):	ACTIVE
170	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SELENOMETHIONINE,(DL):	ACTIVE
171	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SELENOMETHIONINE,(DL):	INACTIVE
172	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	SELENOMETHIONINE,(DL):	INACTIVE
173	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	SELENOMETHIONINE,(DL):	ACTIVE
174	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SELENOMETHIONINE,(DL):	INACTIVE
175	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SELENOMETHIONINE,L:	ACTIVE
176	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SELENOMETHIONINE,L:	ACTIVE
177	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SELENOMETHIONINE,L:	ACTIVE
178	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	SELENOMETHIONINE,L:	INACTIVE
179	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	SELENOMETHIONINE,L:	ACTIVE
180	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SELENOMETHIONINE,L:	INACTIVE
181	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SILYMARIN	ACTIVE
182	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SILYMARIN	ACTIVE
183	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SILYMARIN	INACTIVE
184	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	SILYMARIN	INACTIVE
185	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	SILYMARIN	INACTIVE
186	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SILYMARIN	INACTIVE
187	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTEROL,BETA:	ACTIVE
188	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTEROL,BETA:	ACTIVE
189	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTEROL,BETA:	INACTIVE
190	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTEROL,BETA:	INACTIVE
191	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTEROL,BETA:	ACTIVE
192	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SITOSTEROL,BETA:	INACTIVE
193	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TAURINE	ACTIVE
194	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TAURINE	ACTIVE
195	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TAURINE	ACTIVE
196	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	TAURINE	INACTIVE
197	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	TAURINE	ACTIVE
198	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TAURINE	INACTIVE
199	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TOCOPHEROL,ALPHA: ACETATE	ACTIVE
200	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TOCOPHEROL,ALPHA: ACETATE	ACTIVE
201	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TOCOPHEROL,ALPHA: ACETATE	INACTIVE
202	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	TOCOPHEROL,ALPHA: ACETATE	ACTIVE
203	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	TOCOPHEROL,ALPHA: ACETATE	ACTIVE
204	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TOCOPHEROL,ALPHA: ACETATE	ACTIVE
205	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VANILLIN	ACTIVE
206	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VANILLIN	ACTIVE
207	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VANILLIN	ACTIVE
208	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	VANILLIN	INACTIVE
209	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	VANILLIN	ACTIVE
210	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	VANILLIN	ACTIVE
211	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASCORBIC ACID	ACTIVE
212	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASCORBIC ACID	ACTIVE
213	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASCORBIC ACID	ACTIVE
214	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ASCORBIC ACID	ACTIVE
215	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASCORBIC ACID	ACTIVE
216	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ASCORBIC ACID	ACTIVE
217	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN K-3	ACTIVE
218	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN K-3	ACTIVE
219	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN K-3	INACTIVE
220	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN K-3	ACTIVE
221	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN K-3	ACTIVE
222	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN K-3	ACTIVE
223	TYROSINE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN D-3	ACTIVE
224	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN D-3	ACTIVE
225	POLY(ADP-RIBOSE) SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN D-3	ACTIVE
226	DNA BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN D-3	INACTIVE
227	GLUTATHIONE FORMATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN D-3	ACTIVE
228	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN D-3	INACTIVE

Citation 131131

Citation Details

Summary

Organisms and Their Experiments (2)

Unknown organism

Unknown organism

Show SPARQL Queries (1)

Query 1